The best choice depends on factors like comfort, maintenance ease, and cost
[1] [2] Despite this research interest, retatrutide has not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for clinical use in the United Kingdom
Semaglutide tablets have been approved since 2019 by the United States Food and Drug Administration (FDA) as a treatment of type 2 diabetes (T2D) under the brand name Rybelsus [2, 5]
[DOI] [PMC free article] [PubMed] [Google Scholar] 101.Cunha KS, Barboza EP, Dias EP, Oliveira FM
This combination of both GLP-1 and GIP in one medication creates a complimentary effect that is thought to make tirzepatide more effective for both weight loss and type 2 diabetes than a similar medication , semaglutide, which is the active ingredient in Ozempic and Wegovy
Those who took tirzepatide lost an average of 5.9% of their body weight after three months